Pancreaticobiliary maljunction is associated with common bile duct carcinoma: a meta-analysis.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3893009)

Published in ScientificWorldJournal on December 30, 2013

Authors

Yang Li1, Jun Wei1, Zhongxin Zhao1, Tiangeng You1, Mingan Zhong1

Author Affiliations

1: Department of Gastrointestinal Surgery, East Hospital, Tongji University, 150 Jimo Road, Pudong New District, Shanghai 200120, China.

Articles cited by this

Bias in meta-analysis detected by a simple, graphical test. BMJ (1997) 122.24

Operating characteristics of a rank correlation test for publication bias. Biometrics (1994) 47.97

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (2009) 22.18

Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol (1992) 8.82

Cholangiocarcinoma. Lancet (2005) 6.01

The epidemiology of cholangiocarcinoma. Semin Liver Dis (2004) 5.59

Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer (1995) 3.01

Recent advances in the management of cholangiocarcinomas. Semin Liver Dis (1994) 2.30

Cholangiocarcinoma: modern advances in understanding a deadly old disease. J Hepatol (2006) 2.19

Biliary tract cancer treatment: 5,584 results from the Biliary Tract Cancer Statistics Registry from 1998 to 2004 in Japan. J Hepatobiliary Pancreat Surg (2008) 1.68

Pancreaticobiliary maljunction: retrospective and nationwide survey in Japan. J Hepatobiliary Pancreat Surg (2003) 1.62

Increased lysophosphatidylcholine and pancreatic enzyme content in bile of patients with anomalous pancreaticobiliary ductal junction. Hepatology (1991) 1.32

Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy. Langenbecks Arch Surg (2008) 1.29

Japanese clinical practice guidelines for pancreaticobiliary maljunction. J Gastroenterol (2012) 1.18

Carcinogenesis and chemoprevention of biliary tract cancer in pancreaticobiliary maljunction. World J Gastrointest Oncol (2010) 1.06

Precancerous conditions of biliary tract cancer in patients with pancreaticobiliary maljunction: reappraisal of nationwide survey in Japan. J Hepatobiliary Pancreat Surg (2000) 1.02

K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. Cancer (1996) 1.02

Clinicopathology of pancreaticobiliary maljunction: relationship between alterations in background biliary epithelium and neoplastic development. J Hepatobiliary Pancreat Surg (2005) 1.02

Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients. Cancer (2005) 0.99

An abnormal pancreatico-choledocho-ductal junction in cases of biliary tract carcinoma. Cancer (1983) 0.98

Pancreaticobiliary maljunction: pathophysiological and clinical aspects and the impact on biliary carcinogenesis. Langenbecks Arch Surg (2003) 0.96

Choledochal cyst associated the with anomalous union of pancreaticobiliary duct (AUPBD) has a more grave clinical course than choledochal cyst alone. Korean J Intern Med (1999) 0.95

Long-term results of treatment for pancreaticobiliary maljunction without bile duct dilatation. Arch Surg (2006) 0.94

Risk factors for biliary tract and ampullary carcinomas and prophylactic surgery for these factors. J Hepatobiliary Pancreat Surg (2008) 0.92

Mutagenicity of the bile of dogs with an experimental model of an anomalous arrangement of the pancreaticobiliary duct. Carcinogenesis (1993) 0.91

The choledocho-pancreatico-ductal junction in infantile obstructive jaundice diseases. Acta Pathol Jpn (1980) 0.89

Relationship between pancreaticobiliary maljunction and gallbladder carcinoma: meta-analysis. Hepatobiliary Pancreat Dis Int (2011) 0.89

Pancreaticobiliary diseases associated with anomalous pancreaticobiliary ductal union. Gastrointest Endosc (1998) 0.88

Bile acids and biliary carcinoma in pancreaticobiliary maljunction. Keio J Med (1991) 0.87

Clinical and genetic analysis of noncancerous and cancerous biliary epithelium in patients with pancreaticobiliary maljunction. World J Surg (2001) 0.87

K-ras and p53 gene mutations in noncancerous biliary lesions of patients with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg (2002) 0.86

Relation between K-ras codon 12 mutation and p53 protein overexpression in gallbladder cancer and biliary ductal epithelia in patients with pancreaticobiliary maljunction. J Hepatobiliary Pancreat Surg (2000) 0.85

Biliary tract malignancy and abnormal pancreaticobiliary junction in a Western population. J Gastroenterol Hepatol (2007) 0.85

Helicobacter bilis colonization of the biliary system in patients with pancreaticobiliary maljunction. Br J Surg (2010) 0.83

An 11-year-old male patient demonstrating cholangiocarcinoma associated with congenital biliary dilatation. J Pediatr Surg (2006) 0.81

Pancreatobiliary reflux and the length of a common channel. J Hepatobiliary Pancreat Sci (2010) 0.80